About
Maryland's venture capital ecosystem encompasses a diverse set of firms serving early-stage through growth-stage companies across multiple sectors. Grotech Capital Group operates as a prominent player focusing on early-stage and growth-stage technology companies, providing both capital deployment and strategic advisory support with an emphasis on long-term partnerships and innovation-driven value creation. The Maryland Venture Fund, established in 1994 and based in Columbia, functions as an evergreen early-stage fund dedicated to supporting the next generation of Maryland-based businesses, having invested in approximately 40 companies as of 2019 with a primary focus on Series A rounds. Cleghorn Ventures, founded in 2015 and headquartered in Annapolis, specializes in early-stage and emerging healthcare sector investments. SCI Ventures, one of the longest-established firms in the state with roots dating to 1972, operates from Baltimore with a broad investment mandate. TCP Venture Capital, founded in 2012 and also based in Baltimore, participates in the early-stage investment landscape. New Markets Venture Partners, established in 2003 in Fulton, targets growth-stage companies demonstrating product-market fit with particular emphasis on investments driving both financial returns and improved education and employment outcomes. The region benefits from representation through the Mid-Atlantic Venture Association, a platform connecting capital sources, entrepreneurs, and strategic advisors across the mid-Atlantic technology ecosystem. Together, these firms represent a mature venture capital community serving Maryland's innovation economy across healthcare, technology, and digital media sectors.